Cervical cancer within IIB
Conditions
Interventions
treatment group:Preoperative routine nursing, fasting except carbohydrate diet after 12 PM before surgery, oral carbohydrate (pivotally energy) 800ml at 20:00 PM before surgery, oral carbohydrate (piv
Routine operating room operation
Four hours after the operation, nalbuphine was given 0.2mg/Kg 
control group :Preoperative routine nursing, fasting except carbohydrate diet after 12 PM before surgery, oral carbohydrate (pivotally energy) 800ml at 20:00 PM before surgery, oral carbohydrate (pivo
Routine operation was performed in the operating room during the operation. Three days after
Sponsors
SHENGJING HOSPITAL OF CHINA MEDICAL UNIVERSITY
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Laparotomy for cervical cancer within IIB according to "Guidelines for Diagnosis and Treatment of Cervical Cancer (2021 Edition)"; 2. 18 years old = age = 65 years old; 3. No distant lymph node and blood metastases were found in imaging data; 4. Oral nutritional supplementation was possible; 5. Indications for laparotomy and anesthesia were met; 6. ASA grades I-III; 7. All selected participants agreed to participate in this study and signed.
Exclusion criteria
Exclusion criteria: 1. Laparoscopic surgery; 2. Severe malnutrition requiring supplemental nutrition through enteral and parenteral routes; 3. Chronic kidney disease, ischemic heart disease, or diabetes; 4. Refused to sign the informed consent; 5. Patients admitted to the ICU after surgery; 6. Has been enrolled in other RCT trials; 7. The patient himself or the legally authorized person is unwilling to participate in the trial; 8. The investigator judges that the patient is not suitable for inclusion (such as severe hypoalbuminemia; or potential disputes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Numeric Pain Rating Scale(NPRS); | — |
Secondary
| Measure | Time frame |
|---|---|
| sleep time;Gastrointestinal recovery;visual analogue scale(VAS) score for pain;postoperative complication;Adverse clinical outcome;Blood routine;hepatic and renal function;electrolyte;TNF-a;IL-1ß;IL-6;IL-10;C-reactive protein(CRP);Additional dose and frequency; | — |
Countries
China
Contacts
Public ContactOuyang Ling
Outcome results
None listed